Publication: Serum levels of MIP-1β and rantes in HIV-1 subtype CRF01_ae infected patients with different rates of disease progression
1
Issued Date
2008-09-01
Resource Type
ISSN
01251562
Other identifier(s)
2-s2.0-52649179841
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.39, No.5 (2008), 863-866
Suggested Citation
Thippawan Chuenchitra, Chantapong Wasi, Mark De Souza, Sorachai Nitayaphan, Suda Louisirirotchanakul, Ruengpung Sutthent, Arthur E. Brown, Deborah L. Birx, Victoria R. Polonis Serum levels of MIP-1β and rantes in HIV-1 subtype CRF01_ae infected patients with different rates of disease progression. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.39, No.5 (2008), 863-866. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19567
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Serum levels of MIP-1β and rantes in HIV-1 subtype CRF01_ae infected patients with different rates of disease progression
Abstract
The β-chemokines have been shown to inhibit HIV replication in vitro. To evaluate the role of serum β-chemokines in disease progression and their anti-viral role in vivo, we determined serum levels of macrophage inflammatory protein-1β (MIP-1 β) and regulated upon activation normal T-cell expressed and secreted (RANTES) of twenty HIV-1 subtype CRF01_AE infected patients: nine progressors (PRs, follow-up CD4+ cell count < 200/mm 3 and progression to AIDS or death) and eleven slower progressors (SPs, asymptomatic and/or follow-up CD4+ cell counts >350/mm3 at the end of follow-up) and determined their plasma viral loads. The subjects were followed for at least 36 months. All had initial CD4 values >350 cells/mm3. In this longitudinal study, serum levels of MIP-1β and RANTES in specimens obtained either early or later in the course of HIV infection did not differ significantly between progressors and slower progressors (p > 0.05). There were no significant changes in serum MIP-1β and RANTES levels over time in either patient group (p>0.05). No significant associations were observed between plasma viral loads and the measured β-chemokines (r = -0.205, p = 0.21 for MIP-1β and r = -0.12, p = 0.492 for RANTES). The results suggest these chemokines do not play a major systemic role in control of viremia or protection against the progression of HIV disease.